Literature DB >> 68814

Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.

A Yagoda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 68814

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  Treatment of infiltrating bladder cancer.

Authors:  H J Bloom
Journal:  J R Soc Med       Date:  1979-03       Impact factor: 5.344

2.  Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).

Authors:  P H Smith; J A Child; J H Mulder; A T Van Oosterom; J A Martinez-Pineiro; B Richards; G Stoter; O Dalesio; M De Pauw; R Sylvester
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder.

Authors:  A Maru; H Akaza; S Isaka; K Koiso; T Kotake; T Machida; Y Matsumura; Y Nakagami; T Niijima; K Obata
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Renal function, serum calcium and magnesium during treatment of advanced bladder carcinoma with cis-dichlorodiamineplatinum: impact of tumour site, patient age and magnesium suppletion.

Authors:  J H Blom; K H Kurth; T A Splinter
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

5.  Phase-II trials in patients with urothelial tract tumors. Memorial Sloan-Kettering Cancer Center.

Authors:  A Yagoda
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 6.  Chemotherapy in the management of invasive bladder cancer. A review.

Authors:  H Bush; N Thatcher; R Barnard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.

Authors:  Y Sasaki; T Tamura; K Eguchi; T Shinkai; Y Fujiwara; M Fukuda; Y Ohe; M Bungo; N Horichi; S Niimi
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.

Authors:  J Graziano; B Jones; P Pisciotto
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

9.  Cytotoxic chemotherapy in carcinoma of the bladder: a review.

Authors:  P H Smith
Journal:  J R Soc Med       Date:  1980-03       Impact factor: 18.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.